| 000 | 01066 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250512210853.0 | ||
| 264 | 0 | _c19830826 | |
| 008 | 198308s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/BF00255772 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSlevin, M L | |
| 245 | 0 | 0 |
_aAdjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancer. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _c1983 |
||
| 300 |
_a228-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
| 650 | 0 | 4 |
_aRazoxane _xadministration & dosage |
| 650 | 0 | 4 |
_aRectal Neoplasms _xdrug therapy |
| 700 | 1 | _aHarvey, V J | |
| 700 | 1 | _aWrigley, P F | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 10 _gno. 3 _gp. 228-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00255772 _zAvailable from publisher's website |
| 999 |
_c6344938 _d6344938 |
||